Second Sight Ventures — 2023 Investments

2 investments dated 2023 · listed companies and verified rows first · show all

Tally Healthtallyhealth.com 𝕏Apr 2023 · $10MAcquired

Tally Health offers longevity products including epigenetic aging tests (the TallyAge cheek swab), science-formulated supplements, and personalized DNA-based insights for consumers seeking to slow aging.

Direct to ConsumerLongevityWellness & Fitness

Co-investorsForerunner Ventures Mantis Capital G9 Ventures L Catterton

Other

Tracked investments with no reachable website or further public details — typically companies that wound down, renamed, or were absorbed.

Lucky Beverage

Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.